A Clinical Trial to Study the Effects of Revamilast in Patients With Rheumatoid Arthritis

Clinical trial NCT01430507 · COMPLETED

Trial details

NCT number: NCT01430507
Sponsor: Glenmark Pharmaceuticals Ltd. India
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Rheumatoid Arthritis

Start date: 2011-09-01
Primary completion: 2012-12-01
Enrollment: 406

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.